MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Amiodarone Juno | |
New | Atropine Juno | |
New | Bijuva 1/100 | |
New | Bortezom | |
New | Bortezomib-AFT | |
New | Canesten Once Daily Antifungal Athlete's Foot Cream | |
New | Cefazolin-AFT 2 g | |
New | Copaxone Pen | |
New | Dasatinib Dr.Reddy's | |
New | Ethosuximide Essential Generics (UK) | |
New | Ketamine Interpharma | |
New | Noradrenaline Medsurge | |
New | Noumed Donepezil | |
New | Noumed Fluoxetine | |
New | Plerixafor ARX | |
New | Pyridostigmine Bromide Tablets (Rising Pharmaceuticals) | |
New | Rejuvaskin Skin Recovery Cream | |
New | Rospride | |
New | Scemblix | |
New | Sitagliptin Lupin | |
New | Sogroya | |
New | Tepadina | |
New | Thallous (Tl201) Chloride Injection (Curium) | |
New | Tnkase (USA) | |
New | Velmetia | |
New | Xelevia | |
New | Xenetix (Singapore) | |
New | Xpovio | |
New | Yana | |
New | Yelena | |
Reinstated | Lorstat | |
Revised | 3TC | Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Abacavir/Lamivudine Viatris | Nature and Contents of Container, Product Name change, Qualitative and Quantitative Composition |
Revised | Abyraz | Adverse Effects (Undesirable Effects), Nature and Contents of Container |
Revised | Acarizax | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Accuretic | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Addos XR | TGA Date |
Revised | Aethoxysklerol | TGA Date |
Revised | Agomelatine Sandoz | Special Warnings and Precautions for Use |
Revised | Aimovig | Nature and Contents of Container, Shelf Life, Special Precautions for Storage |
Revised | Aldactone | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Alepam | Nature and Contents of Container |
Revised | Amikacin SXP | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Antroquoril | Fertility, Pregnancy and Lactation |
Revised | APO-Baclofen | Overdose |
Revised | APO-Indapamide SR | Adverse Effects (Undesirable Effects) |
Revised | APO-Latanoprost/Timolol | Adverse Effects (Undesirable Effects) |
Revised | APO-Nifedipine XR | TGA Date |
Revised | APO-Perindopril | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Perindopril Arginine/Amlodipine | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Perindopril/Indapamide 4/1.25 | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Temazepam | TGA Date |
Revised | APO-Zopiclone Tablets | Nature and Contents of Container |
Revised | Arabloc | Special Warnings and Precautions for Use |
Revised | Arava | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Ardix Gliclazide 60 mg MR | TGA Date |
Revised | Ardix Lurasidone | TGA Date |
Revised | Aripiprazole Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Artane | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Augmentin Duo 400 Suspension | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Augmentin Duo, Augmentin Duo Forte Tablets | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Azacitidine-Teva | Dose and Method of Administration, Fertility, Pregnancy and Lactation |
Revised | Bavencio | Pharmacological Properties |
Revised | Betahistine Viatris | Pharmaceutical Form, Product Name change, Special Precautions for Storage |
Revised | Biktarvy Bottle | TGA Date |
Revised | Bivalirudin APOTEX | Incompatibilities, Special Precautions for Storage |
Revised | Blooms the Chemist Perindopril | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Sponsor |
Revised | Boostrix-IPV | List of Excipients |
Revised | Bronchitol | Sponsor |
Revised | BTC Perindopril | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Cambia | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Canesten Plus Antifungal Anti-Inflammatory Cream | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Product Name change, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Celestone-M | Fertility, Pregnancy and Lactation |
Revised | Cervagem | Adverse Effects (Undesirable Effects), New contraindication, Special Warnings and Precautions for Use |
Revised | C-Flox | Adverse Effects (Undesirable Effects) |
Revised | Cilicaine VK | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Ciprofloxacin Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Ciprol | Adverse Effects (Undesirable Effects), Sponsor |
Revised | Clarithromycin Sandoz | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Clomid | Adverse Effects (Undesirable Effects), Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Clonea Clotrimazole Thrush Treatment 3 Day Cream | Sponsor |
Revised | Clonea Clotrimazole Thrush Treatment 6 Day Cream | Sponsor |
Revised | Clopidogrel Winthrop | Special Warnings and Precautions for Use |
Revised | Clozitor | Adverse Effects (Undesirable Effects), Boxed Warnings, Special Warnings and Precautions for Use |
Revised | Comtan | Nature and Contents of Container |
Revised | Coveram | TGA Date |
Revised | Coversyl | TGA Date |
Revised | Coversyl Plus | TGA Date |
Revised | Cozavan | Interactions with Other Medicines and Other Forms of Interactions |
Revised | CSL Hepatitis B Immunoglobulin-VF | Qualitative and Quantitative Composition |
Revised | CSL Normal Immunoglobulin-VF | Product Name change, Qualitative and Quantitative Composition |
Revised | CSL Rh(D) Immunoglobulin-VF | Qualitative and Quantitative Composition |
Revised | CSL Tetanus Immunoglobulin-VF (for Intramuscular Use) | Qualitative and Quantitative Composition |
Revised | CSL Zoster Immunoglobulin-VF | Qualitative and Quantitative Composition |
Revised | Cuvitru | Special Precautions for Storage |
Revised | DBL Dobutamine Hydrochloride Injection | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | DBL Fluorouracil Injection BP | Special Warnings and Precautions for Use |
Revised | DBL Morphine Sulfate Injection | Pharmaceutical Form, Product Name change |
Revised | DBL Pethidine Hydrochloride Injection | Product Name change, Qualitative and Quantitative Composition |
Revised | Dexmedetomidine Accord | Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Dexmedetomidine Ever Pharma | TGA Date |
Revised | Diamicron 60 mg MR | TGA Date |
Revised | Diflucan | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ditropan | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Dovato 50/300 | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Dupixent | Adverse Effects (Undesirable Effects), Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Duride | Nature and Contents of Container, Pharmaceutical Form |
Revised | Eldepryl | Nature and Contents of Container, Pharmaceutical Form, Special Precautions for Storage, Sponsor |
Revised | Eleva | Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Pharmaceutical Form |
Revised | Eligard | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Eltroxin | Special Warnings and Precautions for Use |
Revised | Enhertu | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Epilim IV | Pharmacological Properties |
Revised | Esipram | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Estelle-35 ED | TGA Date |
Revised | Evenity | TGA Date |
Revised | Evrysdi | Special Precautions for Storage |
Revised | Ezetimibe/Atorvastatin GH | TGA Date |
Revised | Fampyra | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Fareston | Sponsor |
Revised | Faverin | TGA Date |
Revised | Felodil XR | TGA Date |
Revised | Fentanyl GH | Special Warnings and Precautions for Use |
Revised | Fluorescite | Shelf Life |
Revised | Fluzole | TGA Date |
Revised | Fucidin | TGA Date |
Revised | Fucidin Topical | Qualitative and Quantitative Composition |
Revised | Galvumet | Adverse Effects (Undesirable Effects) |
Revised | Galvus | Adverse Effects (Undesirable Effects) |
Revised | Ganfort 0.3/5 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ganfort PF 0.3/5 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Glivec | Adverse Effects (Undesirable Effects), List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Glyade | TGA Date |
Revised | Glyade MR | TGA Date |
Revised | Hyrimoz | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Imatinib GH | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Imatinib-Teva | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Iscover | Special Warnings and Precautions for Use |
Revised | Isentress, Isentress HD | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Kadcyla | Special Warnings and Precautions for Use |
Revised | Keytruda | Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Kodatef | Special Precautions for Storage |
Revised | Lacosamide Sandoz | Fertility, Pregnancy and Lactation |
Revised | Lanzopran | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Latuda | TGA Date |
Revised | Ledaga | TGA Date |
Revised | Levophed 1:1,000 | Contraindications |
Revised | Lumigan | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Lumigan PF | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Marevan | Nature and Contents of Container |
Revised | Mavenclad | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation |
Revised | Maviret | Pharmacological Properties |
Revised | Merrem | Adverse Effects (Undesirable Effects) |
Revised | Methotrexate Ebewe | Adverse Effects (Undesirable Effects), Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Metvix | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Shelf Life, Special Warnings and Precautions for Use |
Revised | Micardis | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Overdose, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Micardis Plus | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Midazolam Viatris | Nature and Contents of Container, Product Name change |
Revised | Mirtazapine Sandoz | TGA Date |
Revised | Mizart HCT | Adverse Effects (Undesirable Effects), List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Morphine Sulfate Medsurge | Boxed Warnings, Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Muphoran | Nature and Contents of Container |
Revised | Mysoline | Fertility, Pregnancy and Lactation |
Revised | Natrilix | TGA Date |
Revised | Natrilix SR | TGA Date |
Revised | Nerlynx | Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Normison | TGA Date |
Revised | Norvasc | Pharmaceutical Form |
Revised | Novicrit | Dose and Method of Administration |
Revised | Nuvaxovid | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Odaplix SR | TGA Date |
Revised | Ogivri | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container |
Revised | Opdivo | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Ordine | Qualitative and Quantitative Composition |
Revised | Orion Phenobarbital Elixir | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ozole | Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Ozpan | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Paxlovid | Nature and Contents of Container |
Revised | Pedea | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Pharmacor Ezetimibe Simvastatin | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition |
Revised | Pharmacor Tacrolimus | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | Pharmacy Action Hayfever and Sinus Pain PE | Product Name change |
Revised | Phenobarb | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Phenobarbitone Injection (Aspen Pharmacare) | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Piax | Nature and Contents of Container, Special Precautions for Storage |
Revised | Plaquenil | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Plavix | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Prexum | TGA Date |
Revised | Prexum Combi | TGA Date |
Revised | Pritor/Amlodipine | Adverse Effects (Undesirable Effects), Special Precautions for Storage |
Revised | Reagila | TGA Date |
Revised | Reaptan | TGA Date |
Revised | Revolade | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Ryaltris | Qualitative and Quantitative Composition |
Revised | Rydapt | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties |
Revised | Sandrena | Sponsor |
Revised | Septrin Sugar Free Oral Liquid | Special Precautions for Storage |
Revised | Serc | Pharmaceutical Form, Special Precautions for Storage |
Revised | Sertraline Sandoz | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Signifor | TGA Date |
Revised | Somac Injection | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Somatuline Autogel | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Overdose, Pharmacological Properties |
Revised | Spikevax | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, New Presentation of Brand already available, Pharmacological Properties, Qualitative and Quantitative Composition, Shelf Life, Special Precautions for Storage, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Sporanox Capsules | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Sprycel | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Staphylex | List of Excipients |
Revised | Stelax | Adverse Effects (Undesirable Effects), Overdose |
Revised | Sublocade | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Syntocinon | Nature and Contents of Container, Physicochemical Properties |
Revised | Tacidine | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container |
Revised | Tacrograf | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Tafinlar | TGA Date |
Revised | Tamsil | TGA Date |
Revised | Tecentriq | Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Tecfidera | Adverse Effects (Undesirable Effects) |
Revised | Temizole | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation |
Revised | Temozolomide Juno | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation |
Revised | Temtabs | TGA Date |
Revised | Tenaxil SR | TGA Date |
Revised | Teriflunomide GH | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Tevatiapine XR | Nature and Contents of Container |
Revised | Tobra-Day | Dose and Method of Administration, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Topiramate Sandoz | Special Warnings and Precautions for Use |
Revised | Tremfya | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Twynsta | Adverse Effects (Undesirable Effects), Special Precautions for Storage |
Revised | Ultomiris 100 mg/mL | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Urorec | Pharmacological Properties |
Revised | Vaclovir | Nature and Contents of Container |
Revised | Valprease | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Valpro EC | Pharmacological Properties |
Revised | Valproate Winthrop | Pharmacological Properties |
Revised | Vancomycin Alphapharm | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Vaxzevria | Adverse Effects (Undesirable Effects) |
Revised | Vedafil | TGA Date |
Revised | Vesanoid | Adverse Effects (Undesirable Effects) |
Revised | Vyepti | Adverse Effects (Undesirable Effects) |
Revised | Xalamol 50/5 | Adverse Effects (Undesirable Effects) |
Revised | Xelabine | Special Warnings and Precautions for Use |
Revised | Xtandi | Adverse Effects (Undesirable Effects) |
Revised | Zoely | Contraindications, Special Warnings and Precautions for Use |
Revised | Zoloft | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use, TGA Date |
Revised | Zonegran | Pharmaceutical Form |
Deleted | Bonefos | |
Deleted | Captopril Sandoz | |
Deleted | Ciavor | |
Deleted | Clavam | |
Deleted | Desmopressin Acetate Nasal Solution 10 mcg/0.1 mL spray (Zydus) | |
Deleted | Elevit Morning Sickness Relief | |
Deleted | Elevit Women's Multi | |
Deleted | Elite WPI | |
Deleted | Ephedrine Hydrochloride MYX | |
Deleted | Ethical Nutrients Eczema Shield | |
Deleted | Ethical Nutrients IBS Support | |
Deleted | Herron Riodine Concentrated Gargle | |
Deleted | Latanoprost/Timolol Sandoz | |
Deleted | Mistrom | |
Deleted | Montelukast GH | |
Deleted | Pemetrexed-Teva | |
Deleted | Perindopril and Indapamide AN 4/1.25 | |
Deleted | Quetiapine-AS XR | |
Deleted | Senegar | |
Deleted | Tevaripiprazole | |
Deleted | Thallous (Tl 201) Chloride Injection | |
Deleted | Vancomycin Viatris | |
Deleted | Vedilol | |
Deleted | Vidaza | |
Deleted | Yaz Flex |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au